Подписаться
Sergey Kulemzin
Sergey Kulemzin
Researcher, Institute of Molecular and Cellular Biology SB RAS
Подтвержден адрес электронной почты в домене mcb.nsc.ru
Название
Процитировано
Процитировано
Год
Evasion of the innate immune response: the Old World alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II
I Akhrymuk, SV Kulemzin, EI Frolova
Journal of virology 86 (13), 7180-7191, 2012
2012012
FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA
T Santiago, SV Kulemzin, ES Reshetnikova, NA Chikaev, OY Volkova, ...
International immunology 23 (1), 43-53, 2011
362011
COVID-19. Aetiology, pathogenesis, diagnosis and treatment
VP Baklaushev, SV Kulemzin, АА Gorchakov, VN Lesnyak, ...
Journal of Clinical Practice 11 (1), 7-20, 2020
332020
Challenges and prospects of chimeric antigen receptor T-cell therapy for metastatic prostate cancer
AA Gorchakov, SV Kulemzin, GV Kochneva, AV Taranin
European urology 77 (3), 299-308, 2020
282020
Engineering chimeric antigen receptors
SV Kulemzin, VV Kuznetsova, M Mamonkin, AV Taranin
Acta Naturae (англоязычная версия) 9 (1 (32)), 6-14, 2017
192017
VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells
SV Kulemzin, AA Gorchakov, AN Chikaev, VV Kuznetsova, OY Volkova, ...
Oncotarget 9 (10), 9021, 2018
182018
FCRL6 receptor: Expression and associated proteins
SV Kulemzin, AY Zamoshnikova, MY Yurchenko, NY Vitak, AM Najakshin, ...
Immunology letters 134 (2), 174-182, 2011
182011
Design and analysis of stably integrated reporters for inducible transgene expression in human T cells and CAR NK-cell lines
SV Kulemzin, DA Matvienko, AH Sabirov, AM Sokratyan, DS Chernikova, ...
BMC medical genomics 12 (2), 87-95, 2019
162019
CAR T-cell therapy: Balance of efficacy and safety
SV Kulemzin, VV Kuznetsova, M Mamonkin, AV Taranin, AA Gorchakov
Molecular Biology 51 (2), 237-250, 2017
102017
Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern
AA Gorchakov, SV Kulemzin, SV Guselnikov, KO Baranov, ...
Cell Discovery 7 (1), 1-15, 2021
72021
Combination of Oncolytic Virotherapy and CAR T/NK Cell Therapy for the Treatment of Cancer
GV Kochneva, GF Sivolobova, AV Tkacheva, AA Gorchakov, SV Kulemzin
Molecular Biology 54 (1), 1-12, 2020
72020
Diversity of immunoglobulin light chain genes in non-teleost ray-finned fish uncovers IgL subdivision into five ancient isotypes
SV Guselnikov, KO Baranov, AM Najakshin, LV Mechetina, NA Chikaev, ...
Frontiers in Immunology 9, 2018
62018
Development and Characterization of Domain-Specific Monoclonal Antibodies Produced Against Human SLAMF9
O Volkova, S Guselnikov, L Mechetina, N Chikaev, K Baranov, ...
Monoclonal antibodies in immunodiagnosis and immunotherapy 33 (4), 209-214, 2014
62014
Characterization of human FCRLA isoforms
S Kulemzin, N Chikaev, O Volkova, E Reshetnikova, A Taranin, ...
Immunology letters 152 (2), 153-158, 2013
62013
Analysis of in vitro activity of PSCA-specific CARs in the context of human NK cell line YT
DA Matvienko, SV Kulemzin, AS Smagina, TN Belovezhets, AN Chikaev, ...
Cell Ther. Transplant. 7, 70-76, 2018
52018
shp-2 gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
VG Subrakova, SV Kulemzin, TN Belovezhets, AN Chikaev, NA Chikaev, ...
Vavilov Journal of Genetics and Breeding 24 (1), 80, 2020
42020
Modular lentiviral vector system for chimeric antigen receptor design optimization
SV Kulemzin, NA Chikaev, OY Volkova, VV Kuznetsova, AV Taranin, ...
Russian Journal of Bioorganic Chemistry 43 (2), 107-114, 2017
42017
A simple way to increase recovery of the expressed VH and VL genes in single-sorted human B cells
SV Guselnikov, TN Belovezhets, SV Kulemzin, AA Gorchakov, AV Taranin
BioTechniques 67 (4), 184-187, 2019
32019
Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation
MG Byazrova, SV Kulemzin, EA Astakhova, TN Belovezhets, GA Efimov, ...
Frontiers in immunology 13, 2022
22022
VAV1‐overexpressing YT cells display improved cytotoxicity against malignant cells
AS Smagina, SV Kulemzin, GM Yusubalieva, AG Kedrova, AE Sanzharov, ...
Biotechnology and applied biochemistry 68 (4), 849-855, 2021
12021
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20